March 31, 2020 Hydroxychloroquine Production Surges for COVID-19 The rheumatology community has expressed concerns about the use of hydroxychloroquine sulfate for COVID-19 because the drug is used by patients with systemic lupus erythematosus to control flares and is already in short supply. Over the weekend, the FDA announced that it is taking measures to redistribute the drug to hospitals for COVID-19 patients despite the lack of extensive clinical trial testing.   Guideline Update: Romosozumab in Osteoporosis New treatment guidelines for osteoporosis from the Endocrine Society now include romosozumab for postmenopausal women with severe osteoporosis. Learn more in this report.   RHEUMATOLOGY HEALTHCARE JOB OPPORTUNITIES Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.